paxil pregnancy Il is approved by the FDA for the treatment of depression and several other psychiatric disorders. Results of two early studies reviewed by the FDA showed that women who took Paxil during the first three months of pregnancy were about one and a half to two times as likely to have a baby with a heart defect compared with women who took other antidepressants or women in the general population. Most of the heart defects reported in these studies were of the type known as atrial and ventricular septal defects (holes in the walls of the chambers of the heart). These types of heart defects can range in severity from relatively minor that resolve without treatment paxil pregnancy.
paxil pregnancy To those that cause serious symptoms and need to be repaired surgically. The risk for this type of heart defect is approximately one per cent of births in the general population. In one of the studies with Paxil paxil pregnancy, women taking the drug had an approximately two per cent risk of having a baby with heart defects paxil pregnancy, and in the second study paxil pregnancy, women taking Paxil in the first trimester had an approximate 1.5% risk of having a baby with heart defects. According to the FDA announcement: FDA is advising health care professionals to discuss the potential risk of birth defects with patients taking Paxil who plan to become pregnant or are in their first three months of pregnancy. Health care professionals should consider discontinuing Paxil (and switching to another antidepressant if indicated) in these patients. In some patients paxil pregnancy, the benefits of continuing Paxil may be greater than the potential risk to the fetus. FDA is advising health care professionals not to prescribe Paxil in women who are in the first three months of pregnancy or are planning pregnancy paxil pregnancy, unless other treatment options are not appropriate. The manufacturer of Paxil paxil pregnancy, Glaxo Smith Kline paxil pregnancy, has changed the product labeling from pregnancy class C to class D paxil pregnancy, meaning that that studies in pregnant women (controlled or observational) have demonstrated a risk to the f.
paxil pregnancy Ncy. Health care professionals should consider discontinuing Paxil (and switching to another antidepressant if indicated) in these patients. In some patients paxil pregnancy, the benefits of continuing Paxil may be greater than the potential risk to the fetus. FDA is advising health care professionals not to prescribe Paxil in women who are in the first three months of pregnancy or are planning pregnancy paxil pregnancy, unless other treatment options are not appropriate. The manufacturer of Paxil paxil pregnancy, Glaxo Smith Kline paxil pregnancy, has changed the product labeling from pregnancy class C to class D paxil pregnancy, meaning that that studies in pregnant women (controlled or observational) have demonstrated a risk to the fe.
paxil pregnancy 
paxil pregnancy | | | | | | paxil pregnancy
|